Insulet Reports Third Quarter 2020 Revenue Increase of 22% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Insulet (PODD) Tops Q3 EPS by 9c, Revenues Beat; Raises Revenue Guidance Growth Range
November 4, 2020 5:34 PM ESTInsulet (NASDAQ: PODD) reported Q3 EPS of $0.17, $0.09 better than the analyst estimate of $0.08. Revenue for the quarter came in at $234 million versus the consensus estimate of $221.68 million.
Third Quarter Financial Highlights:
Third quarter 2020 revenue of $234.0 million, up 21.8%, or 19.9% in constant currency1, compared to $192.1 million in the prior year, exceeds guidance of 13% to 15% on a constant currency basisTotal Omnipod revenue of $212.1 million, an increase of 19.7%, or 17.6% in constant currencyU.S. Omnipod revenue of $132.3 million, an increase of 20.9%International Omnipod revenue of $79.8 million, an increase of 17.7%, or 12.4% in constant... More